SCHEMBL990376

SCHEMBL990376

Cc1c(F)cc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 20/20 0.81
BCR P11274 16/20 0.81
KIT P10721 11/20 0.81
ABL2 P42684 5/20 0.81
LYN P07948 4/20 0.81
PDGFRA P16234 3/20 0.81
PDGFRB P09619 3/20 0.81
SRC P12931 2/20 0.81
SYK P43405 2/20 0.81
PLK4 O00444 1/20 0.81
DDX3X O00571 1/20 0.81
GAK O14976 1/20 0.81
SLC22A2 O15244 1/20 0.81
MAPK13 O15264 1/20 0.81
CA12 O43570 1/20 0.81
SLC22A3 O75751 1/20 0.81
ABCB11 O95342 1/20 0.81
EGFR P00533 1/20 0.81
CA1 P00915 1/20 0.81
CA2 P00918 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL989129 0.94 ABL1 (0.71) ABL1BCRKITABL2LYN
SCHEMBL2624943 0.92 ABL1 (0.84) ABL1BCRKITABL2LYN
SCHEMBL988910 0.91 ABL1 (0.82) ABL1BCRKITABL2LYN
Imatinib SCHEMBL3827 0.89 ABL1 (1.00) ABL1BCRKITABL2LYN
SCHEMBL4882244 0.89 ABL1 (0.83) ABL1BCRKITABL2LYN
Imatinib SCHEMBL29351601 0.89 ABL1 (1.00) ABL1BCRKITABL2LYN
Imatinib SCHEMBL2236091 0.89 ABL1 (1.00) ABL1BCRKITABL2LYN
Imatinib SCHEMBL29355523 0.89 ABL1 (1.00) ABL1BCRKITABL2LYN
SCHEMBL3863820 0.89 ABL1 (0.79) ABL1BCRKITABL2LYN
SCHEMBL3860717 0.89 ABL1 (0.85) ABL1BCRKITABL2LYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011008788-A1 FLUORO-SUBSTITUTED COMPOUNDS AS KINASE INHIBITORS AND METHODS OF USE THEREOF ZHANG DAWEI (US) 2011-01-20 WO claimed
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed
CN-102548987-B Fluoro-substituted compounds as kinase inhibitors and methods of use thereof MEDOLUTION LTD JIANGSU CHINA 2014-04-16 CN disclosed
WO-2011008788-A1 FLUORO-SUBSTITUTED COMPOUNDS AS KINASE INHIBITORS AND METHODS OF USE THEREOF ZHANG DAWEI (US) 2011-01-20 WO disclosed
WO-2011008788-A1 FLUORO-SUBSTITUTED COMPOUNDS AS KINASE INHIBITORS AND METHODS OF USE THEREOF ZHANG DAWEI (US) 2011-01-20 WO disclosed